JP2007302683A5 - - Google Patents

Download PDF

Info

Publication number
JP2007302683A5
JP2007302683A5 JP2007180722A JP2007180722A JP2007302683A5 JP 2007302683 A5 JP2007302683 A5 JP 2007302683A5 JP 2007180722 A JP2007180722 A JP 2007180722A JP 2007180722 A JP2007180722 A JP 2007180722A JP 2007302683 A5 JP2007302683 A5 JP 2007302683A5
Authority
JP
Japan
Prior art keywords
solution
homogeneous dispersion
expanding
boiling
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007180722A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007302683A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2007302683A publication Critical patent/JP2007302683A/ja
Publication of JP2007302683A5 publication Critical patent/JP2007302683A5/ja
Pending legal-status Critical Current

Links

JP2007180722A 2000-06-27 2007-07-10 組成物の調製方法 Pending JP2007302683A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002504983A Division JP4149803B2 (ja) 2000-06-27 2001-06-18 組成物の調製方法

Publications (2)

Publication Number Publication Date
JP2007302683A JP2007302683A (ja) 2007-11-22
JP2007302683A5 true JP2007302683A5 (xx) 2008-07-31

Family

ID=8169074

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002504983A Expired - Lifetime JP4149803B2 (ja) 2000-06-27 2001-06-18 組成物の調製方法
JP2007180722A Pending JP2007302683A (ja) 2000-06-27 2007-07-10 組成物の調製方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002504983A Expired - Lifetime JP4149803B2 (ja) 2000-06-27 2001-06-18 組成物の調製方法

Country Status (38)

Country Link
US (3) US6534087B2 (xx)
EP (1) EP1296656B1 (xx)
JP (2) JP4149803B2 (xx)
KR (1) KR100557845B1 (xx)
CN (1) CN1236764C (xx)
AR (1) AR029278A1 (xx)
AT (1) ATE334662T1 (xx)
AU (2) AU8184601A (xx)
BR (1) BRPI0112014B1 (xx)
CA (1) CA2411153C (xx)
CY (1) CY1105714T1 (xx)
CZ (1) CZ301813B6 (xx)
DE (1) DE60121953T2 (xx)
DK (1) DK1296656T3 (xx)
EC (1) ECSP024401A (xx)
EG (1) EG24141A (xx)
ES (1) ES2269441T3 (xx)
HK (1) HK1058314A1 (xx)
HR (1) HRP20021009B1 (xx)
HU (1) HU229550B1 (xx)
IL (2) IL153282A0 (xx)
JO (1) JO2247B1 (xx)
MA (1) MA26922A1 (xx)
ME (1) ME00672B (xx)
MX (1) MXPA02012583A (xx)
MY (1) MY129798A (xx)
NO (1) NO332181B1 (xx)
NZ (1) NZ523024A (xx)
PE (1) PE20020101A1 (xx)
PL (1) PL203804B1 (xx)
PT (1) PT1296656E (xx)
RU (1) RU2244542C2 (xx)
SI (1) SI1296656T1 (xx)
TW (1) TWI278325B (xx)
UY (1) UY26799A1 (xx)
WO (1) WO2002000201A2 (xx)
YU (1) YU96602A (xx)
ZA (1) ZA200209649B (xx)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
AU8184601A (en) * 2000-06-27 2002-01-08 Hoffmann La Roche Method for preparing a composition
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
JP4234017B2 (ja) 2002-04-26 2009-03-04 エフ．ホフマン−ラ ロシュ アーゲー リパーゼ阻害薬及びグルコマンナンを含む医薬組成物
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US8030362B2 (en) * 2003-12-12 2011-10-04 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US20080269223A1 (en) * 2004-04-06 2008-10-30 Saibal Chakravorty Mouth Dissolvable and Meltable, and Water Dispersable Delivery Formulation
EP1790966A1 (en) * 2004-09-15 2007-05-30 Banyu Pharmaceutical Co., Ltd. SAMPLING METHOD AND SAMPLING DEVICE, AND logD MEASURING METHOD AND logD MEASURING SYSTEM
EP2163196A3 (en) * 2004-12-31 2010-11-03 Mikhail Yurievich Gotovsky Device for measuring the presence of foreign substances in a living organism and for individually selecting preparations for increasing an organism's life activity
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
US20060246141A1 (en) * 2005-04-12 2006-11-02 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
WO2006138431A2 (en) * 2005-06-16 2006-12-28 Eastman Chemical Company Methods and pharmaceutical formulations for increasing bioavailability
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
US10010494B2 (en) 2005-10-19 2018-07-03 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
WO2007097325A1 (ja) 2006-02-20 2007-08-30 Chugai Seiyaku Kabushiki Kaisha リン酸オセルタミビル含有医薬組成物
WO2007109127A2 (en) 2006-03-16 2007-09-27 Duke University Methods, systems, and computer program products for performng real-time quadrature projection based fourier domain optical coherence tomography
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (en) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
NZ582049A (en) * 2007-05-18 2012-12-21 Tti Ellebeau Inc Transdermal delivery devices assuring an improved release of an active principle through a biological interface
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
US20100317642A1 (en) * 2007-10-15 2010-12-16 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
WO2010111565A2 (en) 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
PL2435554T3 (pl) 2009-05-26 2018-01-31 Advanced Bionutrition Corp Stabilna kompozycja suchego proszku zawierająca biologicznie aktywne mikroorganizmy i/lub materiały bioaktywne i sposoby jej wykonania
WO2011040956A1 (en) * 2009-09-29 2011-04-07 Michael Burnet Novel pesticide formulations
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
SG182317A1 (en) 2010-01-28 2012-08-30 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
AU2011236907B2 (en) * 2010-04-07 2015-04-02 Mitsubishi Gas Chemical Company, Inc. S-adenosyl-L-methionine-containing dry yeast composition with excellent storage stability and process for producing same
PL2603100T3 (pl) 2010-08-13 2019-06-28 Advanced Bionutrition Corp. Kompozycja stabilizująca przechowywanie na sucho materiałów biologicznych
AU2011320159B2 (en) 2010-10-29 2016-12-22 Western University Of Health Sciences Ternary mixture formulations
AU2012229476B2 (en) 2011-03-01 2016-02-25 The Procter & Gamble Company Porous disintegratable solid substrate for personal health care applications
EP2827905A4 (en) 2012-03-23 2015-05-06 Advanced Bionutrition Corp STABILIZATION COMPOSITION FOR BIOLOGICAL SUBSTANCES
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
DK3314007T3 (da) 2015-06-25 2024-04-22 Native Microbials Inc Fremgangsmåder, apparater og systemer til analyse af mikroorganismestammer fra komplekse heterogene miljøer til forudsigelse og identificering af funktionelle forbindelser og interaktioner derimellem og udvælgelse og syntese af mikrobielle ensembler baseret derpå
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
CA2994112C (en) 2015-07-29 2023-08-08 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
EP3562954A1 (en) 2016-12-28 2019-11-06 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
DE69331839T2 (de) 1992-01-29 2002-12-12 Takeda Chemical Industries Ltd Schnellösliche Tablette und ihre Herstellung
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
NZ262562A (en) * 1993-02-23 1996-04-26 Warner Lambert Co Preparation of solvent free pharmaceutical compositions
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
CN102952033A (zh) 1995-02-27 2013-03-06 吉里德科学公司 新颖化合物,其合成方法及治疗用途
DE759917T1 (de) 1995-02-27 1998-10-22 Gilead Sciences Inc Neue selektive inhibitoren viraler oder bakterieller neuraminidasen
DE69628007T2 (de) * 1995-06-07 2003-11-27 Elan Drug Delivery Ltd Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
EP0893992B1 (en) * 1996-04-16 2004-03-03 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
CN1233169A (zh) * 1996-10-14 1999-10-27 弗·哈夫曼-拉罗切有限公司 一种粉末状制剂的制备工艺
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
ES2272066T3 (es) * 1998-04-09 2007-04-16 F. Hoffmann-La Roche Ag Proceso para la manufactura de particulas con tamaño de (sub)micras por disolucion de gas comprimido y surfactantes.
CN1152680C (zh) * 1998-08-14 2004-06-09 霍夫曼-拉罗奇有限公司 含有脂酶抑制剂和壳聚糖的药物组合物
ATE293970T1 (de) 1998-08-14 2005-05-15 Hoffmann La Roche Lipasehemmer enthaltende pharmazeutische zusammensetzungen
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
ATE400252T1 (de) 1999-02-10 2008-07-15 Pfizer Prod Inc Pharmazeutische feste dispersionen
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
AU8184601A (en) * 2000-06-27 2002-01-08 Hoffmann La Roche Method for preparing a composition

Similar Documents

Publication Publication Date Title
JP2007302683A5 (xx)
JP2010501534A5 (xx)
JP2012502037A5 (xx)
JP2010513478A5 (xx)
JP2007522094A5 (xx)
JP2009502743A5 (xx)
JP2009523771A5 (xx)
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
JP2008533007A5 (xx)
JP2006526031A5 (xx)
CL2006002831A1 (es) Compuestos derivados de sulfonamida: proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad mediada por el receptor de glucocorticoides.
CL2007001992A1 (es) Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege
JP2009520682A5 (xx)
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
JP2010536766A5 (xx)
JP2012517962A5 (xx)
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
WO2010015567A3 (en) Controlled release formulations using intelligent polymers
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
JP2010535814A5 (xx)
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
JP2009505991A5 (xx)
JP2011527299A5 (xx)
IL188643A (en) Derivatives – n (troaryl) –1 – troarylalkyl – 1h – indole – 2– carboxamide, process for the production of derivatives, drug, pharmaceutical composition and use of derivatives for drug production.